GB2191494B - Ligands and methods for augmenting b-cell proliferation - Google Patents

Ligands and methods for augmenting b-cell proliferation

Info

Publication number
GB2191494B
GB2191494B GB8713650A GB8713650A GB2191494B GB 2191494 B GB2191494 B GB 2191494B GB 8713650 A GB8713650 A GB 8713650A GB 8713650 A GB8713650 A GB 8713650A GB 2191494 B GB2191494 B GB 2191494B
Authority
GB
United Kingdom
Prior art keywords
augmenting
ligands
methods
cell proliferation
proliferation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
GB8713650A
Other versions
GB8713650D0 (en
GB2191494A (en
Inventor
Jeffrey A Ledbetter
Edward A Clark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of GB8713650D0 publication Critical patent/GB8713650D0/en
Publication of GB2191494A publication Critical patent/GB2191494A/en
Application granted granted Critical
Publication of GB2191494B publication Critical patent/GB2191494B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6849Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0635B lymphocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/74Inducing cell proliferation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB8713650A 1986-06-13 1987-06-11 Ligands and methods for augmenting b-cell proliferation Expired - Lifetime GB2191494B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87388486A 1986-06-13 1986-06-13

Publications (3)

Publication Number Publication Date
GB8713650D0 GB8713650D0 (en) 1987-07-15
GB2191494A GB2191494A (en) 1987-12-16
GB2191494B true GB2191494B (en) 1990-08-22

Family

ID=25362524

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8713650A Expired - Lifetime GB2191494B (en) 1986-06-13 1987-06-11 Ligands and methods for augmenting b-cell proliferation

Country Status (22)

Country Link
JP (1) JPH0762040B2 (en)
KR (1) KR910004100B1 (en)
AT (1) AT398437B (en)
AU (1) AU617087B2 (en)
BE (1) BE1000587A4 (en)
CA (1) CA1338781C (en)
CH (1) CH676600A5 (en)
CY (1) CY1681A (en)
DE (1) DE3719398C2 (en)
DK (1) DK173940B1 (en)
FR (1) FR2607136B1 (en)
GB (1) GB2191494B (en)
GR (1) GR870930B (en)
HK (1) HK10293A (en)
IE (1) IE60486B1 (en)
IL (1) IL82841A (en)
IT (1) IT1208649B (en)
LU (1) LU86919A1 (en)
NL (1) NL195022C (en)
PT (1) PT85073B (en)
SE (1) SE504675C2 (en)
SG (1) SG118992G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506126A (en) * 1988-02-25 1996-04-09 The General Hospital Corporation Rapid immunoselection cloning method
US5397703A (en) 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
CO4600681A1 (en) 1996-02-24 1998-05-08 Boehringer Ingelheim Pharma PHARMACEUTICAL COMPOSITION FOR IMMUNITY MODULATION

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
EP0117705A3 (en) * 1983-02-24 1985-09-25 The Regents Of The University Of California Monoclonal antibody specific for monocytes and blast cells
FR2547731A1 (en) * 1983-06-27 1984-12-28 Centre Nat Rech Scient ANTITUMOR IMMUNOTOXIN, PHARMACEUTICAL PREPARATIONS CONTAINING IT AND ITS USE IN VITRO
US4585742A (en) * 1983-12-14 1986-04-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibody with specificity to human small cell carcinoma and use thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Cancer, Immu *
Internationa *
J. IMMUNOLOG *
Journal of E *
Proceedings *

Also Published As

Publication number Publication date
IL82841A0 (en) 1987-12-20
SE8702463D0 (en) 1987-06-12
AU617087B2 (en) 1991-11-21
GB8713650D0 (en) 1987-07-15
NL8701371A (en) 1988-01-04
SG118992G (en) 1993-01-29
GR870930B (en) 1987-12-16
IE871563L (en) 1987-12-13
IE60486B1 (en) 1994-07-27
IL82841A (en) 1992-11-15
GB2191494A (en) 1987-12-16
CH676600A5 (en) 1991-02-15
DE3719398A1 (en) 1988-01-28
PT85073B (en) 1990-07-31
FR2607136A1 (en) 1988-05-27
SE8702463L (en) 1987-12-14
KR910004100B1 (en) 1991-06-22
JPS6480299A (en) 1989-03-27
SE504675C2 (en) 1997-04-07
DK173940B1 (en) 2002-03-04
ATA151387A (en) 1994-04-15
HK10293A (en) 1993-02-19
JPH0762040B2 (en) 1995-07-05
DK302287A (en) 1987-12-14
NL195022C (en) 2003-06-18
CY1681A (en) 1993-10-10
DK302287D0 (en) 1987-06-12
AT398437B (en) 1994-12-27
PT85073A (en) 1987-07-01
AU7421487A (en) 1987-12-17
IT1208649B (en) 1989-07-10
IT8720899A0 (en) 1987-06-12
BE1000587A4 (en) 1989-02-14
LU86919A1 (en) 1989-03-08
KR880000582A (en) 1988-03-28
FR2607136B1 (en) 1989-09-15
DE3719398C2 (en) 1996-03-28
CA1338781C (en) 1996-12-10

Similar Documents

Publication Publication Date Title
GB2185840B (en) Cooking apparatus
YU198087A (en) Process for obtaining nor-statine and nor-cyclostatine
GB2224638B (en) Cooking apparatus
GB8615634D0 (en) Combustion apparatus
GB8629468D0 (en) Combustion apparatus
ZA872781B (en) B-cell stimulating factor
GB8617773D0 (en) Cooking apparatus
GB2186512B (en) Sharpening apparatus
GB2218328B (en) Cooking apparatus
GB8622881D0 (en) Timing apparatus
GB2191494B (en) Ligands and methods for augmenting b-cell proliferation
GB8606027D0 (en) Induction apparatus
GB8723491D0 (en) Back support apparatus
GB8714195D0 (en) Food franfer method
GB8300949D0 (en) Kitchen exhaust apparatus
GB8608146D0 (en) Food dressing
GB2222936B (en) Cooking apparatus
GB8620015D0 (en) Combustion apparatus
IE861092L (en) Deposit apparatus
ZA87608B (en) Cooking apparatus
ZA874175B (en) Cooking apparatus
GB8625275D0 (en) Cooking apparatus
CA57232S (en) Grilling apparatus
GB8630394D0 (en) Apparatus for cooking
KR900007967Y1 (en) Multi-purposal cam apparatus in cdp

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20070610